Skip to content

Pelvic Girdle Pain Symptom Severity in Pregnant Women With Gestational Diabetes Mellitus

Investigation of the Effect of Gestational Diabetes Mellitus on Pelvic Girdle Pain Symptom Severity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05403437
Enrollment
155
Registered
2022-06-03
Start date
2022-06-01
Completion date
2025-02-18
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Pelvic Girdle Pain, Pregnant Women

Keywords

pregnant women, pelvic girdle pain, gestational diabetes

Brief summary

Pelvic girdle pain (PGP), which is a common musculoskeletal problem of pregnancy, and gestational diabetes mellitus (GDM), which is diagnosed at the end of the second trimester and at the beginning of the third trimester, occur in a parallel time period. The addition of hyperglycemia to the physiological changes in pregnancy stimulates a new series of cycles and contributes to inflammation, and it is predicted that the presence of GDM may trigger the pain intensity of PGP. Therefore, the aim of this study is to investigate the effect of GDM on PGP symptom severity (pain).

Interventions

Painful areas will be marked on the body chart. The presence and severity of pelvic girdle pain will be determined by the Visual Analog Scale (VAS).

DIAGNOSTIC_TESTEvaluation of pelvic girdle pain diagnostic tests

Pelvic girdle pain diagnostic tests will be applied. The severity of the pain that occurs in positive tests will be evaluated with VAS.

The Pelvic Girdle Questionnaire will be filled.

Sponsors

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have been started. * Pregnant women (with PGP) diagnosed with GDM in the 2nd and 3rd trimesters, whose treatment process (diet/insulin) for insulin regulation have not been started * Pregnant women (with PGP) who were not diagnosed with GDM in the 2nd and 3rd trimesters

Exclusion criteria

* Pre-pregnancy Diabetes Mellitus * Presence of an orthopedic or neurological problem that may cause musculoskeletal disorders and deviations from normal biomechanical alignment * Presence of connective tissue disease * Definition of chronic low back-pelvic region pain (lasting for more than 3 months and pain severity \>4 according to VAS) before pregnancy * History of spine, pelvis, or lower extremity surgery or fracture in the past 6 months * History of pelvic fracture

Design outcomes

Primary

MeasureTime frameDescription
Determining of painful areasBaseline (Current)Marking painful areas on the body chart
Evaluation of painBaseline (Current)Pain will be evaluated with Visual Analog Scale (VAS). The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).
Application of PGP diagnostic testsBaselinePelvic Girdle Pain diagnostic tests will be applied. No score defined for test.
Evaluation of PGP severityBaselineThe severity of the pain that occurs in positive tests will be evaluated with VAS. The VAS is scaled between 0-10 points (0: no pain, 10: most severe pain).

Secondary

MeasureTime frameDescription
Evaluation of Body WeightBaselineMeasuring of the Body Weight
Evaluation of Body Mass Index (BMI)BaselineBMI (kg/m2) will be calculated as person's weight in kilograms divided by the square of height in meters.
Pelvic Girdle QuestionnaireBaselineActivity limitation will be evaluated Pelvic Girdle Questionnaire

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026